1090 related articles for article (PubMed ID: 15922819)
61. Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome.
Kaplan B
Curr Med Res Opin; 2006 Dec; 22(12):2355-64. PubMed ID: 17257450
[TBL] [Abstract][Full Text] [Related]
62. Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients.
Frassetto LA; Tan-Tam CC; Barin B; Browne M; Wolfe AR; Stock PG; Roland M; Benet LZ
Transplantation; 2014 Mar; 97(6):702-7. PubMed ID: 24389906
[TBL] [Abstract][Full Text] [Related]
63. The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.
Grinyó JM; Ekberg H; Mamelok RD; Oppenheimer F; Sánchez-Plumed J; Gentil MA; Hernandez D; Kuypers DR; Brunet M
Nephrol Dial Transplant; 2009 Jul; 24(7):2269-76. PubMed ID: 19357111
[TBL] [Abstract][Full Text] [Related]
64. Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Pharmacotherapy; 2006 Sep; 26(9):1232-40. PubMed ID: 16945044
[TBL] [Abstract][Full Text] [Related]
65. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.
Lam H; Jeffery J; Sitar DS; Aoki FY
Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586
[TBL] [Abstract][Full Text] [Related]
66. Randomized crossover study to assess the inter- and intrasubject variability of morning mycophenolic acid concentrations from enteric-coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipients.
Tedesco-Silva H; Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Slade A; Schmouder R; Medina-Pestana JO
Clin Transplant; 2010; 24(4):E116-23. PubMed ID: 20047618
[TBL] [Abstract][Full Text] [Related]
67. Limited sampling strategy for mycophenolic acid in Japanese heart transplant recipients: comparison of cyclosporin and tacrolimus treatment.
Wada K; Takada M; Kotake T; Ochi H; Morishita H; Komamura K; Oda N; Mano A; Kato TS; Hanatani A; Nakatani T
Circ J; 2007 Jul; 71(7):1022-8. PubMed ID: 17587705
[TBL] [Abstract][Full Text] [Related]
68. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
[TBL] [Abstract][Full Text] [Related]
69. Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients.
Chen H; Peng C; Yu Z; Shen B; Deng X; Qiu W; Fei Y; Shen C; Zhou G; Yang W; Li H
Clin Pharmacokinet; 2007; 46(2):175-85. PubMed ID: 17253887
[TBL] [Abstract][Full Text] [Related]
70. Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients.
Kuypers DR; de Jonge H; Naesens M; de Loor H; Halewijck E; Dekens M; Vanrenterghem Y
Clin Ther; 2008 Apr; 30(4):673-83. PubMed ID: 18498916
[TBL] [Abstract][Full Text] [Related]
71. [Mycophenolic acid concentration profiles may select recipients with high-risk of acute rejection in renal transplant recipients].
Kuriata-Kordek M; Boratyńska M; Urbaniak J; Woźniak M; Patrzałek D; Szyber P; Klinger M
Pol Merkur Lekarski; 2006 Aug; 21(122):161-3; discussion 164. PubMed ID: 17144102
[TBL] [Abstract][Full Text] [Related]
72. Cyclosporine monitoring with 2-hour postdose levels in heart transplant recipients.
Solari SG; Goldberg LR; DeNofrio D; Shaw LM
Ther Drug Monit; 2005 Aug; 27(4):417-21. PubMed ID: 16044096
[TBL] [Abstract][Full Text] [Related]
73. Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy.
Teshima D; Maiguma T; Kaji H; Otsubo K; Kitagawa N; Okabe Y; Sugitani A; Tanaka M; Oishi R
J Clin Pharm Ther; 2008 Apr; 33(2):159-63. PubMed ID: 18315781
[TBL] [Abstract][Full Text] [Related]
74. Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients.
Yeung S; Tsang WK; Tong KL; Wong SH; Lee W; Tang HL; Chan HW; Chan AY
Transplant Proc; 2004 Sep; 36(7):2084-6. PubMed ID: 15518754
[TBL] [Abstract][Full Text] [Related]
75. Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipients.
Ensom MH; Partovi N; Decarie D; Dumont RJ; Fradet G; Levy RD
Ther Drug Monit; 2002 Apr; 24(2):310-4. PubMed ID: 11897977
[TBL] [Abstract][Full Text] [Related]
76. Limited sampling strategy for the estimation of mycophenolic acid area under the concentration-time curve treated in Japanese living-related renal transplant recipients with concomitant extended-release tacrolimus.
Yamaguchi K; Fukuoka N; Kimura S; Watanabe M; Tani K; Tanaka H; Sofue T; Kosaka S; Inui M; Kakehi Y; Houchi H
Biol Pharm Bull; 2013; 36(6):1036-9. PubMed ID: 23558676
[TBL] [Abstract][Full Text] [Related]
77. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.
Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P
Clin Chem; 2001 Jan; 47(1):88-94. PubMed ID: 11148182
[TBL] [Abstract][Full Text] [Related]
78. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
[TBL] [Abstract][Full Text] [Related]
79. Mycophenolate mofetil pharmacokinetic monitoring in pediatric kidney transplant recipients.
Ghio L; Ferraresso M; Viganò SM; Ginevri F; Perfumo F; Gianoglio B; Murer L; Zacchello G; Dello Strologo L; Cardillo M; Tirelli S; Valente U; Edefonti A
Transplant Proc; 2005 Mar; 37(2):856-8. PubMed ID: 15848555
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of mycophenolic acid exposure using a limited sampling strategy in renal transplant recipients.
Li J; Liu Y; Huang J; Fu Q; Chen E; Liu L; Zhang R; Huang M; Wang C
Am J Nephrol; 2013; 37(6):534-40. PubMed ID: 23689735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
